These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 32597318)
1. Acute limb ischemia in a patient with pre-fibrotic myelofibrosis complicated by heparin-induced thrombocytopenia and thrombosis - case report and systematic review of dabigatran use. Di Pilla M; Barco S; Sacco C; Barosi G; Lodigiani C Vasa; 2021 Feb; 50(2):151-156. PubMed ID: 32597318 [No Abstract] [Full Text] [Related]
2. Dabigatran Use after Argatroban for Heparin-induced Thrombocytopenia with Thrombosis: A Case Series and Literature Review. Wang Y; Zhang K; Yin L; Fu G; Liu Z Ann Vasc Surg; 2022 Mar; 80():392.e1-392.e7. PubMed ID: 34656708 [TBL] [Abstract][Full Text] [Related]
3. Direct acting oral anticoagulants for the treatment of suspected heparin-induced thrombocytopenia. Davis KA; Davis DO Eur J Haematol; 2017 Oct; 99(4):332-335. PubMed ID: 28672052 [TBL] [Abstract][Full Text] [Related]
4. Dabigatran as a Treatment Option for Heparin-Induced Thrombocytopenia. Nasiripour S; Saif M; Farasatinasab M; Emami S; Amouzegar A; Basi A; Mokhtari M J Clin Pharmacol; 2019 Jan; 59(1):107-111. PubMed ID: 30285276 [TBL] [Abstract][Full Text] [Related]
5. An overview of heparin-induced thrombocytopenia. Donovan JL; Tran MT; Kanaan AO J Pharm Pract; 2010 Jun; 23(3):226-34. PubMed ID: 21507818 [TBL] [Abstract][Full Text] [Related]
6. A Multicenter Retrospective Evaluation of Direct Oral Anticoagulants for the Treatment of Heparin-Induced Thrombocytopenia. Davis K; Sebaaly J; Wooten L; Khouli C; Mihm A; Nisly SA Am J Cardiovasc Drugs; 2022 Jul; 22(4):417-424. PubMed ID: 35040095 [TBL] [Abstract][Full Text] [Related]
7. Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients. Gray A; Wallis DE; Hursting MJ; Katz E; Lewis BE Clin Appl Thromb Hemost; 2007 Oct; 13(4):353-61. PubMed ID: 17911186 [TBL] [Abstract][Full Text] [Related]
8. Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban. Warkentin TE Thromb Res; 2003 May; 110(2-3):73-82. PubMed ID: 12893020 [TBL] [Abstract][Full Text] [Related]
11. Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis. Frame JN; Rice L; Bartholomew JR; Whelton A Clin Ther; 2010 Apr; 32(4):626-36. PubMed ID: 20435232 [TBL] [Abstract][Full Text] [Related]